Ascendis Pharma A/S Adjustments For Decrease Increase In Prepaid Expenses
Ascendis Pharma A/S (ASND) reported Adjustments For Decrease Increase In Prepaid Expenses of -EUR 6.05 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses · last filed 2026-02-11
- Ascendis Pharma A/S adjustments for decrease increase in prepaid expenses for the quarter ending 2025-12-31 was -4.32M EUR, a 201.19% decline year-over-year.
- Ascendis Pharma A/S adjustments for decrease increase in prepaid expenses for the quarter ending 2025-09-30 was 5.07M EUR, a 19.18% increase year-over-year.
- Ascendis Pharma A/S adjustments for decrease increase in prepaid expenses for the quarter ending 2025-06-30 was -1.28M EUR, a 122.18% decline year-over-year.
- Ascendis Pharma A/S adjustments for decrease increase in prepaid expenses for the quarter ending 2025-03-31 was -5.52M EUR.
| Period end | Adjustments For Decrease Increase In Prepaid Expenses 3 month | Adjustments For Decrease Increase In Prepaid Expenses 6 month | Adjustments For Decrease Increase In Prepaid Expenses 9 month | Adjustments For Decrease Increase In Prepaid Expenses 12 month |
|---|---|---|---|---|
| 2025-12-31 | -4.32M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 750.00K EUR derived: sum of 2 quarters · filed 2026-02-11 | -530.00K EUR derived: sum of 3 quarters · filed 2026-02-11 | -6.05M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 5.07M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 3.79M EUR derived: sum of 2 quarters · filed 2025-11-12 | -1.73M EUR 6-K · filed 2025-11-12 | 2.54M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | -1.28M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | -6.80M EUR 6-K · filed 2025-08-07 | -2.53M EUR derived: sum of 3 quarters · filed 2026-02-11 | 1.72M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | -5.52M EUR 6-K · filed 2025-05-01 | -1.25M EUR derived: sum of 2 quarters · filed 2026-02-11 | 3.00M EUR derived: sum of 3 quarters · filed 2026-02-11 | 8.78M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | 4.27M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 8.53M EUR derived: sum of 2 quarters · filed 2026-02-11 | 14.30M EUR derived: sum of 3 quarters · filed 2026-02-11 | 10.39M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 4.25M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 10.03M EUR derived: sum of 2 quarters · filed 2025-11-12 | 6.12M EUR 6-K · filed 2025-11-12 | 947.00K EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | 5.77M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 1.87M EUR 6-K · filed 2025-08-07 | -3.31M EUR derived: sum of 3 quarters · filed 2026-02-11 | 3.23M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -3.90M EUR 6-K · filed 2025-05-01 | -9.08M EUR derived: sum of 2 quarters · filed 2026-02-11 | -2.54M EUR derived: sum of 3 quarters · filed 2026-02-11 | -5.14M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -5.17M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 1.37M EUR derived: sum of 2 quarters · filed 2026-02-11 | -1.24M EUR derived: sum of 3 quarters · filed 2026-02-11 | -11.41M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | 6.54M EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-14 | 3.94M EUR derived: sum of 2 quarters · filed 2024-11-14 | -6.24M EUR 6-K · filed 2024-11-14 | -3.78M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -2.60M EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-09-03 | -12.78M EUR 6-K · filed 2024-09-03 | -10.32M EUR derived: sum of 3 quarters · filed 2025-02-12 | -9.55M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -10.18M EUR 6-K · filed 2024-05-02 | -7.72M EUR derived: sum of 2 quarters · filed 2025-02-12 | -6.95M EUR derived: sum of 3 quarters · filed 2025-02-12 | -13.86M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | 2.46M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 3.23M EUR derived: sum of 2 quarters · filed 2025-02-12 | -3.68M EUR derived: sum of 3 quarters · filed 2025-02-12 | -6.41M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 768.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | -6.14M EUR derived: sum of 2 quarters · filed 2023-11-07 | -8.87M EUR 6-K · filed 2023-11-07 | -11.86M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | -6.91M EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | -9.64M EUR 6-K · filed 2023-09-05 | -12.63M EUR derived: sum of 3 quarters · filed 2024-02-07 | -13.04M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | -2.73M EUR 6-K · filed 2023-04-27 | -5.72M EUR derived: sum of 2 quarters · filed 2024-02-07 | -6.13M EUR derived: sum of 3 quarters · filed 2024-02-07 | -12.64M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | -2.99M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | -3.41M EUR derived: sum of 2 quarters · filed 2024-02-07 | -9.91M EUR derived: sum of 3 quarters · filed 2024-02-07 | -11.24M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | -414.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-02 | -6.92M EUR derived: sum of 2 quarters · filed 2022-11-02 | -8.25M EUR 6-K · filed 2022-11-02 | |
| 2021-06-30 | -6.50M EUR derived: 6-K 6 month − 6-K 3 month · filed 2022-08-10 | -7.83M EUR 6-K · filed 2022-08-10 | ||
| 2021-03-31 | -1.33M EUR 6-K · filed 2022-05-11 | |||
| 2020-12-31 | -6.36M EUR 20-F · filed 2023-02-16 | |||
| 2019-12-31 | 4.77M EUR 20-F · filed 2022-03-02 |